Skip to main content
OpenTrials

Clinical trial condition

Paramyxoviridae Infections

Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.

354 public trials 28 recruiting studies
Refine in advanced search Browse all conditions

Paramyxoviridae Infections trial results

Completed

Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524

NCT00192478

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • Hospital General de Niños "Ricardo Gutierrez" Buenos Aires, Argentina
  • Hospital Interzonal General de Agudos "Dr. Diego Paroissien Buenos Aires, Argentina
  • Hospital Clinico Pontificia Universidad Catolica de Chile Santiago, Chile
View Trial Details
Completed

Study to Evaluate MEDI-534 in Healthy Adults

NCT00111878

Conditions
Infections, Mononegavirales Infections, Parainfluenza Infections, +5 more
Locations
  • Children's Hospital Columbus, Ohio, United States
  • Primary Physicians Research Pittsburgh, Pennsylvania, United States
  • Radiant Research Dallas, Texas, United States
View Trial Details
Active, Not Recruiting

A Study Evaluating Persistence of the Immune Response of the Adjuvanted Respiratory Syncytial Virus (RSV) Vaccine and the Safety and Immune Response Following Revaccination in Adults 18 Years of Age and Above Who Received Lung or Kidney Transplant

NCT07092865

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Lexington, Kentucky, United States
  • GSK Investigational Site St Louis, Missouri, United States
  • GSK Investigational Site Omaha, Nebraska, United States
  • GSK Investigational Site New York, United States
View all 37 locations
View Trial Details
Active, Not Recruiting

Immunogenicity, Safety, Reactogenicity and Persistence of an Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above

NCT04732871

Conditions
Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
Locations
  • GSK Investigational Site Mobile, Alabama, United States
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Riverside, California, United States
  • GSK Investigational Site San Diego, California, United States
View all 46 locations
View Trial Details

Related conditions